Trials / Completed
CompletedNCT00764257
PREVELLE Shape (CX002) Dermal Filler Protocol
A Multicenter, Evaluator-Masked Study to Assess the Efficacy and Safety of Mentor's CX002 Dermal Filler Medical Device, When Applied as an Intradermal Implant for the Correction of Facial Wrinkles and Lip Augmentation (CX002 Dermal Filler Protocol)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Mentor Worldwide, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to assess PREVELLE Shape (CX002), with respect to safety and efficacy for one year following treatment, for correction of facial nasolabial folds and when applied as an intradermal implant for lip augmentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PREVELLE Shape | |
| DEVICE | Restylane |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2008-10-02
- Last updated
- 2011-12-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00764257. Inclusion in this directory is not an endorsement.